FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2899795257> ?p ?o ?g. }

• W2899795257 endingPage "201" @default.
• W2899795257 startingPage "196" @default.
• W2899795257 abstract "Background Inhibition of the interaction of programmed death 1 with programmed death ligand 1 and 2 has been used successfully for treatment of multiple advanced cancers, but expression has not been studied in adrenocortical carcinoma. In this study, we investigated programmed death ligand 1 and 2 expression in adrenocortical carcinoma to determine the potential usefulness of checkpoint inhibitors in these malignant neoplasms. Methods A total of 56 tissue samples from patients with adrenocortical carcinoma (34) and benign adrenal tissues (22) were identified. Immunohistochemistry was performed for programmed death ligand 1, programmed death ligand 2, and CD8 and scored for membranous staining on adrenal and stromal tissue according to the immunoreactive score and absolute percentage, respectively. Descriptive statistics, a Mann-Whitney U test, and Fisher exact tests were calculated. Results In total, 15 adrenocortical carcinoma (44%) stained positive for programmed death ligand 2 and 1 adrenocortical carcinoma for programmed death ligand 1 (P = .03). Adrenocortical carcinoma samples were more likely to express programmed death ligand 2 on tumor cells or in stromal tissues than benign samples (OR = 2.3, P = .03). There was no relationship between programmed death ligand 2 and CD8 expression (P = .08). There were also no relationships between programmed death ligand 2 or CD8 expression and tumor characteristics. Conclusion Programmed death ligand 2, but not programmed death ligand 1, is expressed commonly in adrenocortical carcinoma samples. The utility of certain checkpoint inhibitors should, therefore, be evaluated in further studies." @default.
• W2899795257 created "2018-11-16" @default.
• W2899795257 creator A5007600129 @default.
• W2899795257 creator A5009903271 @default.
• W2899795257 creator A5010951213 @default.
• W2899795257 creator A5014064580 @default.
• W2899795257 creator A5028357898 @default.
• W2899795257 creator A5030261063 @default.
• W2899795257 creator A5047639268 @default.
• W2899795257 creator A5050394769 @default.
• W2899795257 creator A5059916310 @default.
• W2899795257 creator A5071082421 @default.
• W2899795257 creator A5079606439 @default.
• W2899795257 creator A5087677775 @default.
• W2899795257 date "2019-01-01" @default.
• W2899795257 modified "2023-10-14" @default.
• W2899795257 title "Expression of programmed death ligand 1 and 2 in adrenocortical cancer tissues: An exploratory study" @default.
• W2899795257 cites W1967352082 @default.
• W2899795257 cites W1972162697 @default.
• W2899795257 cites W1981648862 @default.
• W2899795257 cites W1994325777 @default.
• W2899795257 cites W2017712207 @default.
• W2899795257 cites W2066671159 @default.
• W2899795257 cites W2072709644 @default.
• W2899795257 cites W2095692889 @default.
• W2899795257 cites W2130207101 @default.
• W2899795257 cites W2166662937 @default.
• W2899795257 cites W2171081063 @default.
• W2899795257 cites W2277555391 @default.
• W2899795257 cites W2300386653 @default.
• W2899795257 cites W2505238445 @default.
• W2899795257 cites W2626773261 @default.
• W2899795257 cites W2745207660 @default.
• W2899795257 cites W2766118475 @default.
• W2899795257 doi "https://doi.org/10.1016/j.surg.2018.04.086" @default.
• W2899795257 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30413322" @default.
• W2899795257 hasPublicationYear "2019" @default.
• W2899795257 type Work @default.
• W2899795257 sameAs 2899795257 @default.
• W2899795257 citedByCount "13" @default.
• W2899795257 countsByYear W28997952572019 @default.
• W2899795257 countsByYear W28997952572020 @default.
• W2899795257 countsByYear W28997952572021 @default.
• W2899795257 countsByYear W28997952572022 @default.
• W2899795257 countsByYear W28997952572023 @default.
• W2899795257 crossrefType "journal-article" @default.
• W2899795257 hasAuthorship W2899795257A5007600129 @default.
• W2899795257 hasAuthorship W2899795257A5009903271 @default.
• W2899795257 hasAuthorship W2899795257A5010951213 @default.
• W2899795257 hasAuthorship W2899795257A5014064580 @default.
• W2899795257 hasAuthorship W2899795257A5028357898 @default.
• W2899795257 hasAuthorship W2899795257A5030261063 @default.
• W2899795257 hasAuthorship W2899795257A5047639268 @default.
• W2899795257 hasAuthorship W2899795257A5050394769 @default.
• W2899795257 hasAuthorship W2899795257A5059916310 @default.
• W2899795257 hasAuthorship W2899795257A5071082421 @default.
• W2899795257 hasAuthorship W2899795257A5079606439 @default.
• W2899795257 hasAuthorship W2899795257A5087677775 @default.
• W2899795257 hasConcept C116569031 @default.
• W2899795257 hasConcept C121608353 @default.
• W2899795257 hasConcept C126322002 @default.
• W2899795257 hasConcept C142724271 @default.
• W2899795257 hasConcept C170493617 @default.
• W2899795257 hasConcept C190283241 @default.
• W2899795257 hasConcept C204232928 @default.
• W2899795257 hasConcept C2777546739 @default.
• W2899795257 hasConcept C2781399356 @default.
• W2899795257 hasConcept C31573885 @default.
• W2899795257 hasConcept C502942594 @default.
• W2899795257 hasConcept C55493867 @default.
• W2899795257 hasConcept C71924100 @default.
• W2899795257 hasConcept C86803240 @default.
• W2899795257 hasConceptScore W2899795257C116569031 @default.
• W2899795257 hasConceptScore W2899795257C121608353 @default.
• W2899795257 hasConceptScore W2899795257C126322002 @default.
• W2899795257 hasConceptScore W2899795257C142724271 @default.
• W2899795257 hasConceptScore W2899795257C170493617 @default.
• W2899795257 hasConceptScore W2899795257C190283241 @default.
• W2899795257 hasConceptScore W2899795257C204232928 @default.
• W2899795257 hasConceptScore W2899795257C2777546739 @default.
• W2899795257 hasConceptScore W2899795257C2781399356 @default.
• W2899795257 hasConceptScore W2899795257C31573885 @default.
• W2899795257 hasConceptScore W2899795257C502942594 @default.
• W2899795257 hasConceptScore W2899795257C55493867 @default.
• W2899795257 hasConceptScore W2899795257C71924100 @default.
• W2899795257 hasConceptScore W2899795257C86803240 @default.
• W2899795257 hasIssue "1" @default.
• W2899795257 hasLocation W28997952571 @default.
• W2899795257 hasLocation W28997952572 @default.
• W2899795257 hasOpenAccess W2899795257 @default.
• W2899795257 hasPrimaryLocation W28997952571 @default.
• W2899795257 hasRelatedWork W1986212507 @default.
• W2899795257 hasRelatedWork W2021314610 @default.
• W2899795257 hasRelatedWork W2055479802 @default.
• W2899795257 hasRelatedWork W2082308871 @default.
• W2899795257 hasRelatedWork W2372890110 @default.
• W2899795257 hasRelatedWork W2389345732 @default.
• W2899795257 hasRelatedWork W2393167104 @default.

• next